To assess the conservation status of endemic species we examined the population trends in three frog species with different life histories. We performed a mark-recapture field experiment in a protected area on the eastern flank of the Cordillera Central in the northern Andes of Colombia. We marked and followed 123 individuals of Pristimantis jaguensis, 178 Colostethus aff. fraterdanieli, and 83 Dendrobates truncatus. The survival probability and the population growth rate of P. jaguensis varied as a function of capture occasion, while the recapture probability was constant. In the two dendrobatids, C. aff. fraterdanieli and D. truncatus, survival and recapture probabilities were constant over time and the population growth rate indicated the populations were stables during monitoring. Long-term monitoring programs are recommended to establish with certainty the conservation status of each species. However, in the perspective of the current biodiversity crisis in which rapid management decisions must be made, it is necessary to draw on the available data even if its limited. Although our demographic dataset is limited in time, we demonstrated how this information constitutes a starting point to understand the conservation status of these frog populations and to establish standard methods to continue long-term monitoring programs.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.